ISMO: Improving Screening for Macular Oedema Improving the value of screening for diabetic macular oedema using surrogate photographic markers.

Role of the Trial Steering Committee

“Monitoring is defined as the act of overseeing the progress of a clinical trial, and of ensuring that it is conducted, recorded and reported in accordance with the protocol, Standard Operating Procedures, Good Clinical Practice (GCP) and the applicable regulatory requirements.”
Note for Guidance on Good Clinical Practice, European Medicines Agency 2006 CPMP/ICH/135/95.

Members of the Trial Steering Committee

• Dr Rod Harvey, Consultant Diabetologist, NHS Highland. Chairperson
• Prof Alex Elliott, Consultant Medical Physicist, NHS Glasgow.
• Dr A. Manivannan, Medical Physicist, NHS Grampian.
• Mr Steve Graham, Patient Representative.
• Dr John Olson, Consultant Ophthalmologist. Chief Investigator.
• Prof Peter Sharp, Consultant Medical Physicist. Co-investigator.